Showing posts with label
BEAM
.
Show all posts
Showing posts with label
BEAM
.
Show all posts
Monday, May 26, 2025
As genetic medicine technology continues to advance, we own both BEAM and CRSPR for their cutting edge tech!
›
Business & Investment Report: Combined Investment Strategy in Beam Therapeutics (BEAM) and CRISPR Therapeutics (CRSP) Executive Summary...
Friday, December 6, 2024
It is never wrong to take profit. We're staying long stocks, but skimming some cream from the top today!
›
This week we trimmed some high flyers. Here's the run down! IONQ up over 400% since our buy in - Trimmed today 1/2 QBTS since we bega...
Sunday, December 1, 2024
Three companies are leading the charge into Gene editing technology and medical advancements that seek to cure otherwise incurable diseases!
›
A Comparative Analysis of Intellia Therapeutics, CRISPR Therapeutics, and Beam Therapeutics Executive Summary This report presents a compa...
Tuesday, June 25, 2024
Going forward, how viable is Beam Therapeutics in the BioTech market?
›
Fr: ChatGPT Beam Therapeutics appears to be a viable biotechnology company, with several strengths that contribute to its potential: Finan...
›
Home
View web version
